Testosterone Therapy Heart Attack Cases Set to Go to Trial
December 2nd, 2014|
Hormones control many of aspects of our bodies, including mood, bone strength, muscle mass, and sex drive. But as we age, our bodies produce less of these hormones, which can affect the way body systems work.
And while hormone replacement therapies are available, patients who choose certain treatments may be putting their health at serious risk.
A good example of this comes from recent lawsuits filed in connection with testosterone therapy heart attacks. Victims claim companies failed to warn them that testosterone replacement products, such as AndroGel®, might put them at an increased risk of suffering cardiovascular injuries, including stroke and heart attacks.
An order from the United States Judicial Panel on Multidistrict Litigation states certain bellwether cases related to low T therapy injuries are expected to go to trial as early as 2016.
A judge went on to explain that six cases will be selected to go to trial. The results of those cases will be used to determine the future of hundreds of similar cases. The trials will only include injuries involving the use of Androgel®.
At Ferrer, Poirot & Wansbrough, we have more than 35 years of experience protecting the rights of drug injury victims. If you or a loved one suffered a heart attack or stroke after using Androgel®, our drug injury lawyers are here to help. Call us 24/7 at (800) 210-8503 to get in touch with our legal team today.